SCHEMBL942902

SCHEMBL942902

NC(=O)C(CCC1CCCCC1)N1CCN(C2CCCC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.48
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
METAP1 P53582 1/20 0.39
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PHGDH O43175 1/20 0.36
MGLL Q99685 1/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HIF1A Q16665 1/20 0.36
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
CCR3 P51677 2/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL943648 0.73 CHRM1 (0.36) SIGMAR1MEN1KMT2ACHRM2CHRM1
SCHEMBL942650 0.73 SIGMAR1 (0.52) SIGMAR1POLBALDH1A1TSHR
SCHEMBL1553960 0.71 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ACHRM2CHRM1
SCHEMBL29957200 0.70 CHRM2 (0.44) SIGMAR1CHRM2CHRM1POLBHSD17B10
SCHEMBL27549748 0.68 METAP1 (0.50) SIGMAR1METAP1
SCHEMBL21540294 0.68 METAP1 (0.55) METAP1
SCHEMBL10305559 0.68 METAP1 (0.55) METAP1
SCHEMBL1017572 0.67 SIGMAR1 (0.39) SIGMAR1CHRM2CHRM1POLBHSD17B10
SCHEMBL931400 0.66 METAP1 (0.49) SIGMAR1METAP1
SCHEMBL13582 0.66 METAP1 (0.49) SIGMAR1METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed